Eyenovia Inc.

1.58+0.0300+1.94%Vol 341.92K1Y Perf -27.91%
Oct 4th, 2023 16:00 DELAYED
BID1.54 ASK1.66
Open1.55 Previous Close1.55
Pre-Market- After-Market1.66
 - -  0.08 5.06%
Target Price
12.00 
Analyst Rating
Strong Buy 1.00
Potential %
659.49 
Finscreener Ranking
★★★★     52.46
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
     38.90
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
     38.59
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
1.84 
Earnings Rating
Strong Buy
Market Cap60.37M 
Earnings Date
9th Nov 2023
Alpha-0.00 Standard Deviation0.24
Beta1.68 

Today's Price Range

1.531.67

52W Range

1.505.85

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-8.14%
1 Month
-17.28%
3 Months
-36.55%
6 Months
-56.71%
1 Year
-27.91%
3 Years
-51.53%
5 Years
-59.49%
10 Years
-

TickerPriceChg.Chg.%
EYEN1.580.03001.94
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
1.70
2.70
0.44
0.36
-27.60
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
100.00
-182.40
-179.40
-
-99.25
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.20-0.1620.00
Q01 2023-0.19-0.1521.05
Q04 2022-0.21-0.1719.05
Q03 2022-0.20-0.21-5.00
Q02 2022-0.18-0.22-22.22
Q01 2022--0.24-
Q04 2021-0.10-
Q03 2021-0.26-0.2311.54
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.2016.67Positive
12/2023 QR-0.253.85Positive
12/2023 FY-0.694.17Positive
12/2024 FY-0.803.61Positive
Next Report Date9th Nov 2023
Estimated EPS Next Report-0.20
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume341.92K
Shares Outstanding38.21K
Shares Float29.50M
Trades Count1.70K
Dollar Volume545.50K
Avg. Volume205.49K
Avg. Weekly Volume155.48K
Avg. Monthly Volume227.30K
Avg. Quarterly Volume233.69K

Eyenovia Inc. (NASDAQ: EYEN) stock closed at 1.58 per share at the end of the most recent trading day (a 1.94% change compared to the prior day closing price) with a volume of 341.92K shares and market capitalization of 60.37M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 29 people. Eyenovia Inc. CEO is Tsontcho Ianchulev.

The one-year performance of Eyenovia Inc. stock is -27.91%, while year-to-date (YTD) performance is -3.07%. EYEN stock has a five-year performance of -59.49%. Its 52-week range is between 1.5 and 5.85, which gives EYEN stock a 52-week price range ratio of 1.84%

Eyenovia Inc. currently has a PE ratio of -3.30, a price-to-book (PB) ratio of 3.20, a price-to-sale (PS) ratio of 5.82, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -67.04%, a ROC of -93.51% and a ROE of -153.85%. The company’s profit margin is -99.25%, its EBITDA margin is -179.40%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Eyenovia Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. Eyenovia Inc.’s next earnings report date is 09th Nov 2023.

The consensus rating of Wall Street analysts for Eyenovia Inc. is Strong Buy (1), with a target price of $12, which is +659.49% compared to the current price. The earnings rating for Eyenovia Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Eyenovia Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Eyenovia Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.02, ATR14 : 0.10, CCI20 : -140.40, Chaikin Money Flow : -0.20, MACD : -0.09, Money Flow Index : 44.03, ROC : -10.92, RSI : 34.16, STOCH (14,3) : 10.00, STOCH RSI : 0.31, UO : 35.47, Williams %R : -90.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Eyenovia Inc. in the last 12-months were: Charles E. Mather (Buy at a value of $7 470), Ianchulev Tsontcho (Sold 270 000 shares of value $1 275 000 ), Michael M. Rowe (Buy at a value of $15 400), Rowe Michael (Buy at a value of $15 400), Rowe Michael (Sold 0 shares of value $-27 200 ), Stuart M. Grant (Buy at a value of $32 630), Tsontcho Ianchulev (Sold 120 000 shares of value $480 000 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Eyenovia Inc.

Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

CEO: Tsontcho Ianchulev

Telephone: +1 917 289-1117

Address: 295 Madison Avenue, New York 10017, NY, US

Number of employees: 29

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

57%43%

Bearish Bullish

56%44%

 

News

Stocktwits